Events
Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis therapeutics.
London: Monday, November 11, 2019: Hutchison China MediTech Limited announces that Christian Hogg, Chief Executive Officer, will present at the following conferences
TrialScope Announces Winners of 2nd Annual Clārus Awards
Genedata Selector® deployed to streamline complex cell line development processes
The Company reaffirms that it will file for the lurbinectedin NDA to the FDA under accelerated approval regulations for the treatment of relapsed Small Cell Lung Cancer (SCLC) during the fourth quarter (Q4) of 2019.
Zelluna Immunotherapy, a biopharma company developing T-cell receptor guided adoptive cell therapy products for treatment of multiple solid cancers, announces it will present data on its lead TCR compound, ZI-H04 at a poster session.
BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, announced that has established a Singapore-based entity in order to spearhead its activities in the Asia Pacific region, including China.
Carestream will introduce a three-dimensional extension of general radiography through its Digital Tomosynthesis functionality clearance) at this year’s Radiological Society of North America conference in booth #7513, North Hall..
MorphoSys AG announced presentation of so far unpublished data on tafasitamab, its proprietary key asset and investigational hemato-oncological drug candidate, at the upcoming 61th American Society of Hematology 2019 Annual Meeting, taking place from December 7-10, 2019 in Orlando, Florida.
Summit Therapeutics plc announces that management will participate in two panel sessions at the World Antimicrobial Resistance Congress, taking place 7-8 November 2019 in Washington, DC.
PRESS RELEASES